House Of Lords To Hear Amgen,TKT Patent Dispute Next Week
England's highest court, the House of Lords, will hear the long-running patent dispute between Amgen and Transkaryotic Therapies/Hoechst over the blockbuster blood booster hormone erythropoietin (epo) next week....To view the full article, register now.
Already a subscriber? Click here to view full article